Chiron Diagnostics Receives 510(k) Clearance for ACS:Centaur Immunoassay System.WALPOLE, Ma.--(BW HealthWire)--Aug. 7, 1997--Chiron Diagnostics, a business unit of Chiron Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CHIR CHIR Chiricahua National Monument (US National Park Service) ) announced today that it received official communication from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. confirming clearance of their Premarket Notification - 510(k) for the ACS (Asynchronous Communications Server) See network access server. :Centaur centaur (sĕn`tôr), in Greek mythology, creature, half man and half horse. The centaurs were fathered by Ixion or by Centaurus, who was Ixion's son. (TM) Chemiluminescent chem·i·lu·mi·nes·cence n. Emission of light as a result of a chemical reaction at environmental temperatures. chem Immunoassay System. The ACS:Centaur is an automated immunoassay system designed to optimize the productivity of the clinical laboratory. Scheduled to launch in late 1997, the ACS:Centaur will dramatically increase the overall productivity of the laboratory by providing fast reliable diagnostic information while minimizing the operator's hands-on time. "We are pleased to have received this news," said Fran Tuttle, Senior Vice President of Immunodiagnostics. "The timing couldn't have been better given the enthusiastic reception the ACS:Centaur received at the AACC AACC American Association of Community Colleges (formerly American Association of Junior Colleges) AACC American Association for Clinical Chemistry AACC American Association of Cereal Chemists AACC Anne Arundel Community College in July, and it comes on the heels of our successful initial productivity trials." Recently, at the American Association for Clinical Chemists' (AACC) annual meeting in Atlanta, Georgia, the company hosted a Forum where close to 200 customers had the opportunity to preview initial productivity trial data. These "Alpha Trials" were conducted at four leading institutions in Europe and the U.S. and demonstrated the excellent productivity and ease-of-use of the ACS:Centaur. Chiron Diagnostics Corporation combines biological technologies, chemistry and advanced systems to empower physicians with information to better manage therapies and help patients understand their disease. Chiron Diagnostics has operations in more than 20 countries, sells its products in over 90 countries and employs approximately 3,500 people. Its products include automated instrumentation, reagents, controls, and nucleic acid systems to quantify viral load. Chiron Diagnostics focuses its advanced diagnostic technologies in Critical Blood Analysis, Clinical Chemistry, Endocrinology, Infectious Disease, Allergy, and Oncology, and is a business unit of Chiron Corporation, headquartered in Emeryville, California. CONTACT: Chiron Corporation Judith Rossi, 508/660-4875 (Corporate Communications) Pam Pasakarnis, 617/551-7745 (U.S. Operations) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion